Table 2. Correlation of miR-1, 133a, 133b and 206 with overall survival.

	All RMS patients			Fusion-negative patients
miRNA	No. of patients	HR (95% CI)	Log-rank test (P)	No. of patients	HR (95% CI)	Log-rank test (P)
miR-206 expression
High miR-206	40	1	0.003	31	1	0.005
Med miR-206	79	2.1 (0.9–4.7)		38	2.0 (0.6–6.5)
Low miR-206	40	3.7 (1.7–8.4)**		26	4.9 (1.6–15.0)**
miR-1 expression
High miR-1	40	1	0.515	16	1	0.229
Med miR-1	79	0.9 (0.5–1.6)		45	0.9 (0.5–1.6)
Low miR-1	40	1.2 (0.6–2.5)		34	1.2 (0.6–2.5)
miR-133a expression
High miR-133a	40	1	0.859	21	1	0.314
Med miR-133a	79	1.2 (0.6–2.2)		40	0.9 (0.3–2.9)
Low miR-133a	40	1.2 (0.6–2.4)		34	1.7 (0.6–4.9)
miR-133b expression
High miR-133b	40	1	0.355	21	1	0.161
Med miR-133b	79	1.2 (0.6–2.3)		44	1.4 (0.4–4.3)
Low miR-133b	40	1.6 (0.8–3.3)		30	2.5 (0.8–7.8)

Abbreviations: CI=confidence interval; HR=Hazard Ratio; miRNA=microRNA; RMS= rhabdomyosarcoma.

^**P<0.01.